跳至主要内容
临床试验/NCT02951793
NCT02951793Unknown不适用

Effect of Recent Alcohol, Smoking and Psychotropic Drug Use on Delirium in ICU

Seoul National University Hospital1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2016年3月最近更新:
适应症

试验速览

阶段
不适用
入组人数
200
试验地点
1
主要终点
Delirium during ICU stay

研究概览

简要总结

Investigators are seeking to determine the impact of recent alcohol, smoking or psychotropic drug use prior to intensive care unit (ICU) admission on incidence of delirium and sedation requirements.

Study design: A prospective observational study, in a medical ICU of a tertiary university hospital.

Methods: For all new ICU admissions, a 1-page questionnaire including Alcohol Use Disorders Identification Test (AUDIT-C), smoking history and prior medication use was given to the patient or closest family members.

Delirium was assessed by trained ICU nurses using Intensive Care Delirium Screening Checklist and Richmond Agitation-Sedation Scale.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients who are older than 18 years of age
  • New patients admitted to medical ICU for the 1st time during their stay in hospital

排除标准

  • Had history of stroke or other primary neurologic disease
  • GCS ≤ 8 prior to ICU admission
  • Transferred from other ICU (except for emergency ICU stay which is limited to less than 36 hours)
  • Not registered within 24 hours after admission
  • Refused to participate
  • If comatous state persists
  • Delirium assessment is not possible due to newly developed neurologic disease, such as cerebral infarction
  • Medical ICU stay less than 24 hours
  • Readmission to medical ICU

结局指标

主要结局

Delirium during ICU stay

时间窗: From date of ICU admission until the date of ICU discharge, whichever came first, assessed up to 3 months

次要结局

  • ICU length of stay(From date of ICU admission until the date of first documented discharge from ICU or death, whichever came first, assessed up to 3 months)
  • Maximal doses of dexmedetomidine(From date of ICU admission until the date of first documented discharge from ICU or death, whichever came first, assessed up to 3 months)
  • Cumulative dose of dexmedetomidine(From date of ICU admission until the date of first documented discharge from ICU or death, whichever came first, assessed up to 3 months)
  • Mortality(From date of ICU admission until the date of death, assessed up to 3 months)
  • Cumulative dose of midazolam(From date of ICU admission until the date of first documented discharge from ICU or death, whichever came first, assessed up to 3 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jinwoo Lee

Professor

Seoul National University Hospital

研究点 (1)

Loading locations...

相似试验